Publisher Correction: TET2 is required to suppress mTORC1 signaling through urea cycle with therapeutic potential

被引：0
|
作者：
Jing He
Mingen Lin
Xinchao Zhang
Ruonan Zhang
Tongguan Tian
Yuefan Zhou
Wenjing Dong
Yajing Yang
Xue Sun
Yue Dai
Yue Xu
Zhenru Zhang
Ming Xu
Qun-Ying Lei
Yanping Xu
Lei Lv
机构：
[1] Fudan University,MOE Key Laboratory of Metabolism and Molecular Medicine, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences
[2] Tongji University,Tongji Hospital, Shanghai Key Laboratory of Signaling and Disease Research, Frontier Science Center for Stem Cell Research, School of Life Sciences and Technology
[3] Tongji University,Shanghai Key Laboratory of Maternal Fetal Medicine, Clinical and Translational Research Center of Shanghai First Maternity and Infant Hospital
[4] UConn Center on Aging,Fudan University Shanghai Cancer Center and Cancer Metabolism Laboratory, Institutes of Biomedical Sciences, Shanghai Medical College
[5] UConn Health,undefined
[6] Fudan University,undefined
来源：
Cell Discovery | / 9卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Novel Regulation of mTORC1 Through mRNA Binding Protein ZFP36L2 is Required for Normal Cardiac Function.
    Kouzu, Hidemichi
    Chang Hsiang-Chun
    DeJesus, Adam
    Shapiro, Jason
    Xia, Eric
    Stanczyk, Paulina
    Blackshear, Perry
    Ardehali, Hossein
    CIRCULATION, 2018, 138
  • [32] Peptide drugs accelerate BMP-2-induced calvarial bone regeneration and stimulate osteoblast differentiation through mTORC1 signaling
    Sugamori, Yasutaka
    Mise-Omata, Setsuko
    Maeda, Chizuko
    Aoki, Shigeki
    Tabata, Yasuhiko
    Murali, Ramachandran
    Yasuda, Hisataka
    Udagawa, Nobuyuki
    Suzuki, Hiroshi
    Honma, Masashi
    Aoki, Kazuhiro
    BIOESSAYS, 2016, 38 (08) : 717 - 725
  • [33] Combined Inhibition of mTORC1 and mTORC2 Signaling Pathways Is a Promising Therapeutic Option in Inhibiting Pheochromocytoma Tumor Growth: In Vitro and In Vivo Studies in Female Athymic Nude Mice
    Giubellino, Alessio
    Bullova, Petra
    Noelting, Svenja
    Turkova, Hana
    Powers, James F.
    Liu, Qingsong
    Guichard, Sylvie
    Tischler, Arthur S.
    Grossman, Ashley B.
    Pacak, Karel
    ENDOCRINOLOGY, 2013, 154 (02) : 646 - 655
  • [34] High-density lipoprotein protects normotensive and hypertensive rats against ischemia-reperfusion injury through differential regulation of mTORC1 and mTORC2 signaling
    Al-Othman, Reham
    Al-Jarallah, Aishah
    Babiker, Fawzi
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [35] Sestrin2 protects against bavachin induced ER stress through AMPK/mTORC1 signaling pathway in HepG2 cells
    Yang, Ying
    Guo, Guiming
    Zhou, Wei
    Ge, Yunxuan
    Fan, Zheng
    Liu, Qingquan
    Gao, Yue
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2021, 145 (02) : 175 - 186
  • [36] Metabolic Reprogramming of Alloreactive T Cells Through TCR/MYC/mTORC1/E2F6 Signaling in aGvHD Patients
    Pan, Zengkai
    Huang, Aijie
    He, Yang
    Zhang, Zilu
    Jiang, Chuanhe
    Wang, Luxiang
    Qing, Kai
    Zhang, Sujiang
    Wang, Jianmin
    Hu, Xiaoxia
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [37] Sestrin2 Suppresses Classically Activated Macrophages-Mediated Inflammatory Response in Myocardial Infraction through Inhibition of mTORC1 Signaling
    Yang, Keping
    Xu, Chenhong
    Zhang, Yunfeng
    He, Shaolin
    Li, Dazhu
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [38] The Intracellular Cleavage Product o the NG2 Proteoglycan Modulates Translation and Cell-Cycle Kinetics via Effects on mTORC1/FMRP Signaling
    Nayak, Tanmoyita
    Trotter, Jacqueline
    Sakry, Dominik
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2018, 12
  • [39] Dual Inhibition of PI3K and mTORC1/2 Signaling by NVP-BEZ235 as a New Therapeutic Strategy for Acute Myeloid Leukemia
    Chapuis, Nicolas
    Tamburini, Jerome
    Green, Alexa S.
    Vignon, Christine
    Bardet, Valerie
    Neyret, Aymeric
    Pannetier, Melanie
    Willems, Lise
    Park, Sophie
    Macone, Alexandre
    Maira, Sauveur-Michel
    Ifrah, Norbert
    Dreyfus, Francois
    Herault, Olivier
    Lacombe, Catherine
    Mayeux, Patrick
    Bouscary, Didier
    CLINICAL CANCER RESEARCH, 2010, 16 (22) : 5424 - 5435
  • [40] Correction: NUCB2/Nesfatin-1 drives breast cancer metastasis through the up-regulation of cholesterol synthesis via the mTORC1 pathway
    Siyi Ning
    Caiying Liu
    Kangtao Wang
    Yubo Cai
    Zhicheng Ning
    Ming Li
    Liang Zeng
    Journal of Translational Medicine, 21
12345